Free Trial
ASX:IDX

Integral Diagnostics (IDX) Stock Price, News & Analysis

Integral Diagnostics logo

About Integral Diagnostics Stock (ASX:IDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
240,828 shs
Average Volume
N/A
Market Capitalization
A$1.10 billion
P/E Ratio
N/A
Dividend Yield
1.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDX Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
See More Headlines

IDX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Integral Diagnostics investors own include electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Credit Suisse Group (CS), Chimerix (CMRX), Capricor Therapeutics (CAPR) and Bathurst Resources (BRL).

Company Calendar

Today
8/28/2025
Ex-Dividend for 10/2 Dividend
8/28/2025
Record date for 10/2 Dividend
10/02/2025
Dividend Payable
10/02/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:IDX
CIK
N/A
Fax
N/A
Employees
2,010
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.39
Net Income
-A$60.70 million
Net Margins
-12.92%
Pretax Margin
N/A
Return on Equity
-20.16%
Return on Assets
3.36%

Debt

Debt-to-Equity Ratio
118.59
Current Ratio
0.86
Quick Ratio
1.84

Sales & Book Value

Annual Sales
A$469.70 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
23.99
Book Value
A$1.29 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
233,960,000
Free Float
N/A
Market Cap
A$1.10 billion
Optionable
Not Optionable
Beta
0.73
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (ASX:IDX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners